體外診斷市場規模、佔有率和成長分析：按產品/服務、技術、應用、檢測地點、最終用戶、檢體和地區分類－2026-2033年產業預測

2024 年全球體外診斷 (IVD) 市值為 1,000 億美元，預計到 2025 年將成長至 2033 年的 1,486.1 億美元，預測期（2026-2033 年）複合年成長率為 4.5%。

體外診斷市場正經歷強勁成長，這主要得益於慢性病和感染疾病的日益普遍、技術的進步以及人們健康意識的提高。約70%的臨床決策都受到診斷測試的影響，體外診斷在現代醫學中扮演著至關重要的角色。人口老化、個人化醫療的日益普及以及政府加強診斷基礎設施的舉措，都進一步推動了市場擴張。此外，人們對早期精準診斷的需求日益成長，尤其是在癌症和糖尿病等疾病的診斷方面。分子診斷、就地檢驗和人工智慧整合工具等創新技術正在改變產業格局。儘管診斷檢查室和醫院對這些技術的應用，以及研發投入的增加，正在推動產品多樣化，但監管障礙和保險報銷方面的挑戰可能會阻礙市場成長。

全球體外診斷市場成長要素

慢性病盛行率的上升和對早期診斷解決方案需求的不斷成長是推動全球體外診斷市場擴張的關鍵因素。相當一部分人口患有慢性病，許多人同時患有多種疾病。這種盛行率的上升使得人們迫切需要有效的診斷工具，以便及時介入並改善患者的治療效果。隨著醫療保健系統努力提高其慢性病管理能力，創新體外診斷技術日益受到關注，這也促進了市場的整體成長。

全球體外診斷市場限制因素

全球體外診斷市場面臨嚴峻挑戰，主要原因是各地法規嚴格且不斷變化，缺乏統一性。這些差異往往導致產品核准大幅延誤、成本增加，並阻礙創新。例如，日本獨特的分類體系將體外診斷試劑和醫療設備的法規分開，這令海外製造商感到困惑。因此，血糖儀和試紙等在其他市場通常被歸類為同一類別的產品，在日本卻必須經過不同的監管流程。這種複雜性不僅增加了合規難度，也延長了新產品上市所需的時間。

全球體外診斷市場趨勢

全球體外診斷市場正經歷顯著成長，這主要得益於人們對早期疾病檢測重要性的認知不斷提高，以及對更快、更精準的診斷解決方案的需求日益成長。就地檢驗和攜帶式診斷設備的日益普及進一步推動了這一趨勢，這些設備有助於提高醫療服務的可近性，並改善患者的治療效果。調查方法的技術進步和數位健康解決方案的整合在市場擴張中發揮著至關重要的作用。此外，對個人化醫療的日益重視有望為診斷領域的創新創造新的機遇，並提升服務品質。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球體外診斷市場規模：依產品/服務分類

• 裝置
• 試劑
• 服務

全球體外診斷市場規模：依技術分類

• 核心技術
  • 免疫檢測
  • 臨床化學
  • 分子診斷
  • 血液學
  • 凝血
  • 微生物學
  • 其他

全球體外診斷市場規模：按應用領域分類

• 感染疾病
• 糖尿病
• 腫瘤學
• 循環系統
• 腎臟病學
• 自體免疫疾病
• 藥物檢測
• 其他

全球體外診斷市場規模：依檢測地點分類

• 臨床試驗
• 即時偵測（POC​​）
• 居家照護

全球體外診斷市場規模：依最終用戶分類

• 醫院
• 研究所
• 居家照護
• 其他

全球體外診斷市場規模：依樣本數分類

• 血
• 尿
• 唾液
• 組織
• 其他

全球體外診斷市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Roche
• Abbott
• Thermo Fisher Scientific
• Siemens Healthineers
• Becton Dickinson
• Danaher
• Sysmex
• bioMerieux
• QIAGEN
• Hologic
• Illumina
• Agilent Technologies
• Bio-Rad Laboratories
• DiaSorin
• QuidelOrtho
• Quest Diagnostics
• Labcorp
• Grifols
• Werfen
• Exact Sciences

結論與建議

Global In-Vitro Diagnostics Market size was valued at USD 100.0 Billion in 2024 and is poised to grow from USD 104.5 Billion in 2025 to USD 148.61 Billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The in-vitro diagnostics market is experiencing robust growth, driven by the rising prevalence of chronic and infectious diseases, technological advancements, and heightened healthcare awareness. With approximately 70% of clinical decisions influenced by diagnostic testing, IVD plays a crucial role in modern healthcare. The aging population and increasing adoption of personalized medicine, alongside government initiatives to enhance diagnostic infrastructure, further catalyze market expansion. Additionally, the demand for early and precise diagnostics, particularly for conditions like cancer and diabetes, is escalating. Innovations such as molecular diagnostics, point-of-care testing, and AI-integrated tools are transforming the landscape. The integration of these technologies in diagnostic laboratories and hospitals, coupled with rising investments in R&D, is propelling product diversification, although regulatory hurdles and reimbursement challenges may impede growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In-Vitro Diagnostics Market Segments Analysis

Global In-Vitro Diagnostics Market is segmented by Product / Offering, Technology, Application, Test Location, End-User, Sample and region. Based on Product / Offering, the market is segmented into Instruments, Reagents and Services. Based on Technology, the market is segmented into Core Technologies. Based on Application, the market is segmented into Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing and Others. Based on Test Location, the market is segmented into Laboratory Testing, Point-of-Care (POC) and Home-care. Based on End-User, the market is segmented into Hospitals, Laboratories, Home Care and Others. Based on Sample, the market is segmented into Blood, Urine, Saliva, Tissue and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In-Vitro Diagnostics Market

The rise in the incidence of chronic diseases and the growing demand for early diagnostic solutions are key factors propelling the expansion of the global in-vitro diagnostics market. A significant portion of the population is affected by chronic ailments, with many individuals experiencing multiple conditions simultaneously. This increasing prevalence creates an urgent need for effective diagnostic tools that can facilitate timely interventions and improve patient outcomes. As healthcare systems strive to enhance their capabilities in managing chronic illnesses, the emphasis on innovative in-vitro diagnostic technologies is becoming more pronounced, contributing to the market's overall growth trajectory.

Restraints in the Global In-Vitro Diagnostics Market

The global In-Vitro Diagnostics market faces considerable challenges due to stringent and evolving regulations that lack harmonization across different regions. These varying requirements often lead to significant delays in product approvals, heightened costs, and barriers to innovation. For example, Japan's distinct classification system separates the regulation of IVD agents and devices, which can create confusion for international manufacturers. Consequently, products such as glucose meters and test strips, typically categorized similarly in other markets, must navigate divergent regulatory pathways in Japan. This complexity not only complicates compliance efforts but also prolongs market entry timelines for new products.

Market Trends of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is experiencing notable growth driven by a surge in awareness regarding early disease detection and the shifting demand for faster, more accurate diagnostic solutions. This trend is further supported by the increasing adoption of point-of-care testing and portable diagnostic devices, which facilitate greater accessibility and improve patient outcomes. Technological advancements in testing methodologies and the integration of digital health solutions are playing a crucial role in expanding the market. Additionally, the growing emphasis on personalized medicine is expected to create new opportunities for innovation and enhance service delivery in the diagnostics sector.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global In-Vitro Diagnostics Market Size by Product / Offering & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents
• Services

Global In-Vitro Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Core Technologies
  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Coagulation
  • Microbiology
  • Others

Global In-Vitro Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Drug Testing
• Others

Global In-Vitro Diagnostics Market Size by Test Location & CAGR (2026-2033)

• Market Overview
• Laboratory Testing
• Point-of-Care (POC)
• Home-care

Global In-Vitro Diagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Laboratories
• Home Care
• Others

Global In-Vitro Diagnostics Market Size by Sample & CAGR (2026-2033)

• Market Overview
• Blood
• Urine
• Saliva
• Tissue
• Others

Global In-Vitro Diagnostics Market Size & CAGR (2026-2033)

• North America (Product / Offering, Technology, Application, Test Location, End-User, Sample)
  • US
  • Canada
• Europe (Product / Offering, Technology, Application, Test Location, End-User, Sample)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product / Offering, Technology, Application, Test Location, End-User, Sample)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product / Offering, Technology, Application, Test Location, End-User, Sample)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product / Offering, Technology, Application, Test Location, End-User, Sample)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations